A diagnostic approach and natural course of a patient with asthma–COPD overlap syndrome. Issue 4 (8th October 2015)

• Record Type: Journal Article
• Authors: Lee, Hyun; Tho, Nguyen Van; Nakano, Yasutaka; Lee, Byung‐Jae; Park, Hye Yun
• Is Part Of: Respirology case reports. Volume 3:Issue 4(2015:Dec.)
• Page Start: 119
• Page End: 121
• Publication Date: 2015-10-08
• Subjects: Asthma -- chronic obstructive pulmonary disease -- diagnosis; Respiratory organs -- Diseases -- Periodicals; 616.2005
• DOI: 10.1002/rcr2.130
• Languages: English
• ISSNs: 2051-3380

Abstract

Abstract: The diagnostic criteria of asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) advocated by the Global Initiative for Asthma (GINA)/Global Initiative for Chronic Obstructive Lung Disease (GOLD) are somewhat complicated, and limited data are available regarding how ACOS patients respond to current medications. We present a case of a 64‐year‐old man with ACOS. With features favoring asthma including childhood asthma history with intermittent episodes of dyspnea at night, elevated blood eosinophil count and total IgE, increased forced expiratory volume in 1 s (FEV1 ) after bronchodilator (>200 mL and >12% from baseline), and positive skin prick tests, he also had features favoring COPD such as heavy smoker, persistent exertional dyspnea, and airflow limitation after inhaled therapy. Over 5‐year follow up, our patient experienced a single episode of moderate exacerbation. However, post‐bronchodilator FEV1 decreased by 240 mL for 4 years (−60 mL/year) after 1.5 years of treatment, indicating rapid lung function decline. Longitudinal studies are necessary to assess optimal interventions and natural course of ACOS. Abstract : The diagnostic criteria of asthma‐chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is advocated by GINA/GOLD but limited data are available regarding how ACOS patients respond to current medications. We present a case of a 64‐year‐old man with clinical features of both asthma and COPD. Over five years follow‐up with combination treatment with inhaled corticosteroids and bronchodilators, he experienced a single episode of moderate exacerbation. However, post‐bronchodilator FEV1 decreased by 240mL for 4 years (‐60mL/yr), indicating rapid lung function decline. Longitudinal studies are necessary to assess optimal interventions and natural course of ACOS. See review in Respirology http://dx.doi.org/10.1111/resp.12653